Merck is evaluating Welireg in advanced RCC and other tumour types through a broad clinical ... NCT03401788 ) evaluating Welireg for the treatment of patients with VHL disease who had at least one ...
However, more than 30% of patients, including some older adults and those with pre-existing kidney disease or hearing loss, cannot take cisplatin due to severe ... of durvalumab and cetuximab-in ...